DNA methylation-based biomarkers for early detection of non-small cell lung cancer: an update
<p>Abstract</p> <p>Lung cancer is the number one cancer killer in the United States. This disease is clinically divided into two sub-types, small cell lung cancer, (10–15% of lung cancer cases), and non-small cell lung cancer (NSCLC; 85–90% of cases). Early detection of NSCLC, whic...
Main Authors: | Laird-Offringa Ite A, Alonzo Todd A, Anglim Paul P |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2008-10-01
|
Series: | Molecular Cancer |
Online Access: | http://www.molecular-cancer.com/content/7/1/81 |
Similar Items
-
Identification of a panel of sensitive and specific DNA methylation markers for lung adenocarcinoma
by: Hagen Jeffrey A, et al.
Published: (2007-10-01) -
DNA methylation changes in atypical adenomatous hyperplasia, adenocarcinoma in situ, and lung adenocarcinoma.
by: Suhaida A Selamat, et al.
Published: (2011-01-01) -
Genome-scale screen for DNA methylation-based detection markers for ovarian cancer.
by: Mihaela Campan, et al.
Published: (2011-01-01) -
Epigenetic Therapy in Lung Cancer
by: Stephen V Liu, et al.
Published: (2013-05-01) -
DNA methylation biomarkers for early detection of gastric and colorectal cancers
by: Xianchun Gao, et al.
Published: (2023-12-01)